A randomized, double blind, cross-over, placebo-controlled clinical trial to assess the effects of Candesartan on the insulin sensitivity on non diabetic, non hypertense subjects with dysglyce mia and abdominal obesity. "ARAMIA"

Article

Abstract: Background: The raising prevalence of type-2 diabetes mellitus and obesity has been recognized as a

Palabras claves:

Autores:

Lahera V., Márquez G.A., PATRICIO LOPEZ -JARAMILLO, Pradilla L.P., Rueda-Clausen C.F., Silva-Sieger F.A.

Fuentes:

google

scopus